B

Bonne Co Ltd
KOSDAQ:226340

Watchlist Manager
Bonne Co Ltd
KOSDAQ:226340
Watchlist
Price: 1 458 KRW 0.69% Market Closed
Market Cap: ₩25B

Bonne Co Ltd
Note Receivable

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Bonne Co Ltd
Note Receivable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
B
Bonne Co Ltd
KOSDAQ:226340
Note Receivable
₩620.5m
CAGR 3-Years
N/A
CAGR 5-Years
-8%
CAGR 10-Years
N/A
AmorePacific Corp
KRX:090430
Note Receivable
₩21B
CAGR 3-Years
8%
CAGR 5-Years
-1%
CAGR 10-Years
-4%
Amorepacific Group
KRX:002790
Note Receivable
₩22.9B
CAGR 3-Years
6%
CAGR 5-Years
-2%
CAGR 10-Years
-4%
Cosmax Inc
KRX:192820
Note Receivable
₩28.7B
CAGR 3-Years
24%
CAGR 5-Years
18%
CAGR 10-Years
N/A
LG H&H Co Ltd
KRX:051900
Note Receivable
₩7.5B
CAGR 3-Years
-2%
CAGR 5-Years
3%
CAGR 10-Years
6%
Kolmar Korea Co Ltd
KRX:161890
Note Receivable
₩0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Bonne Co Ltd
Glance View

Market Cap
25B KRW
Industry
Consumer products

Bonne Co., Ltd. engages in the business of cosmetics and personal care products development for various brands. The company is headquartered in Seoul, Seoul. The company went IPO on 2015-11-05. The Company’s products mainly consist of washable lotion, foundation, BB cream, CC cream, cleaning sticks, cleaning fluid, cleaning balm, eye shadow, eye liner, blusher, lip sticks, lip gloss and facial masks.

Intrinsic Value
1 400.95 KRW
Overvaluation 4%
Intrinsic Value
Price ₩1 458
B

See Also

What is Bonne Co Ltd's Note Receivable?
Note Receivable
620.5m KRW

Based on the financial report for Sep 30, 2025, Bonne Co Ltd's Note Receivable amounts to 620.5m KRW.

What is Bonne Co Ltd's Note Receivable growth rate?
Note Receivable CAGR 5Y
-8%

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett